Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting

Summary

Northwest Biotherapeutics announced that its Chief Technical Officer will present scientific data on propensity score matching at the British Neuro-Oncology Society Annual Meeting. This is a routine conference presentation regarding the company's DCVax personalized immune therapy program.